| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drugs, Chinese Herbal | 23 | 2024 | 147 | 10.510 |
Why?
|
| Breast Neoplasms | 220 | 2025 | 21163 | 9.410 |
Why?
|
| Receptor, erbB-2 | 97 | 2025 | 2588 | 8.000 |
Why?
|
| Brain Neoplasms | 96 | 2025 | 9197 | 6.590 |
Why?
|
| Tripterygium | 10 | 2020 | 16 | 5.560 |
Why?
|
| Glycosides | 9 | 2020 | 100 | 5.330 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 69 | 2024 | 11854 | 3.750 |
Why?
|
| Volatile Organic Compounds | 6 | 2023 | 86 | 3.710 |
Why?
|
| Breast Neoplasms, Male | 8 | 2024 | 212 | 2.700 |
Why?
|
| Quinazolines | 23 | 2021 | 1374 | 2.660 |
Why?
|
| alpha-Thalassemia | 10 | 2024 | 53 | 2.600 |
Why?
|
| Central Nervous System Neoplasms | 15 | 2025 | 930 | 2.550 |
Why?
|
| DNA Copy Number Variations | 23 | 2024 | 2046 | 2.390 |
Why?
|
| Prenatal Diagnosis | 31 | 2024 | 1274 | 2.310 |
Why?
|
| Neuralgia | 5 | 2022 | 622 | 1.970 |
Why?
|
| Receptors, Estrogen | 36 | 2025 | 2247 | 1.930 |
Why?
|
| Female | 388 | 2025 | 397050 | 1.710 |
Why?
|
| China | 50 | 2024 | 2389 | 1.680 |
Why?
|
| Antineoplastic Agents | 45 | 2023 | 13696 | 1.640 |
Why?
|
| Humans | 531 | 2025 | 768298 | 1.630 |
Why?
|
| Neoplasm Recurrence, Local | 27 | 2024 | 9433 | 1.600 |
Why?
|
| Neoplasm Metastasis | 46 | 2024 | 4921 | 1.590 |
Why?
|
| Carcinoma, Ductal, Breast | 8 | 2023 | 1094 | 1.570 |
Why?
|
| Air Pollutants | 18 | 2021 | 2900 | 1.540 |
Why?
|
| Carcinoma, Hepatocellular | 10 | 2021 | 2331 | 1.540 |
Why?
|
| Tablets | 10 | 2022 | 149 | 1.530 |
Why?
|
| Receptors, Progesterone | 24 | 2021 | 1145 | 1.520 |
Why?
|
| Liver Neoplasms | 14 | 2021 | 4360 | 1.490 |
Why?
|
| Chromosome Aberrations | 17 | 2024 | 1780 | 1.490 |
Why?
|
| Analgesics | 5 | 2022 | 1070 | 1.470 |
Why?
|
| Radiosurgery | 11 | 2023 | 1346 | 1.460 |
Why?
|
| beta-Thalassemia | 10 | 2024 | 236 | 1.460 |
Why?
|
| Fetus | 15 | 2024 | 1883 | 1.450 |
Why?
|
| Medicine, Chinese Traditional | 4 | 2020 | 75 | 1.390 |
Why?
|
| Neoplasm Staging | 48 | 2024 | 11254 | 1.370 |
Why?
|
| Chemotherapy, Adjuvant | 30 | 2022 | 3553 | 1.360 |
Why?
|
| Air Pollution, Indoor | 8 | 2022 | 915 | 1.320 |
Why?
|
| Paclitaxel | 14 | 2021 | 1736 | 1.300 |
Why?
|
| Tamoxifen | 9 | 2020 | 968 | 1.260 |
Why?
|
| Femur Head Necrosis | 3 | 2014 | 133 | 1.250 |
Why?
|
| Artemisinins | 2 | 2022 | 217 | 1.200 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2020 | 3776 | 1.130 |
Why?
|
| Prognosis | 74 | 2025 | 30020 | 1.130 |
Why?
|
| Arthritis, Experimental | 2 | 2019 | 293 | 1.100 |
Why?
|
| BRCA2 Protein | 4 | 2023 | 802 | 1.100 |
Why?
|
| Meningeal Carcinomatosis | 5 | 2023 | 66 | 1.050 |
Why?
|
| Immunoconjugates | 4 | 2024 | 969 | 1.050 |
Why?
|
| Middle Aged | 184 | 2025 | 223463 | 1.040 |
Why?
|
| BRCA1 Protein | 6 | 2023 | 1158 | 1.030 |
Why?
|
| Methotrexate | 4 | 2020 | 1722 | 1.030 |
Why?
|
| Environmental Monitoring | 15 | 2022 | 1463 | 1.030 |
Why?
|
| Adult | 178 | 2025 | 223622 | 1.010 |
Why?
|
| Clinical Trials as Topic | 20 | 2020 | 8051 | 1.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 5 | 2016 | 622 | 0.990 |
Why?
|
| Breast | 14 | 2024 | 1975 | 0.970 |
Why?
|
| Aged | 143 | 2025 | 171544 | 0.930 |
Why?
|
| HSP90 Heat-Shock Proteins | 4 | 2019 | 423 | 0.880 |
Why?
|
| Carcinoma, Lobular | 3 | 2018 | 480 | 0.880 |
Why?
|
| Hepatic Stellate Cells | 3 | 2020 | 117 | 0.880 |
Why?
|
| Jaundice, Neonatal | 1 | 2023 | 71 | 0.880 |
Why?
|
| Maytansine | 4 | 2020 | 88 | 0.840 |
Why?
|
| Neoplasms | 21 | 2024 | 22389 | 0.830 |
Why?
|
| Biopsy | 13 | 2024 | 6808 | 0.830 |
Why?
|
| SEER Program | 13 | 2024 | 1474 | 0.820 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2023 | 164 | 0.800 |
Why?
|
| Sclera | 1 | 2023 | 189 | 0.790 |
Why?
|
| Glioma | 7 | 2021 | 3526 | 0.790 |
Why?
|
| Central Nervous System | 4 | 2023 | 1346 | 0.780 |
Why?
|
| Electronic Waste | 1 | 2021 | 4 | 0.770 |
Why?
|
| Ketones | 5 | 2021 | 182 | 0.770 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 255 | 0.760 |
Why?
|
| Hydrops Fetalis | 3 | 2023 | 113 | 0.760 |
Why?
|
| Furans | 5 | 2021 | 201 | 0.760 |
Why?
|
| Occupational Exposure | 3 | 2021 | 1817 | 0.760 |
Why?
|
| Chromosome Disorders | 5 | 2024 | 499 | 0.760 |
Why?
|
| Filgrastim | 4 | 2020 | 131 | 0.750 |
Why?
|
| Mastectomy | 9 | 2023 | 1851 | 0.750 |
Why?
|
| Antirheumatic Agents | 3 | 2020 | 1378 | 0.740 |
Why?
|
| alpha Karyopherins | 1 | 2021 | 42 | 0.740 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 997 | 0.740 |
Why?
|
| ROC Curve | 6 | 2024 | 3622 | 0.740 |
Why?
|
| Protein Kinase Inhibitors | 14 | 2022 | 5707 | 0.740 |
Why?
|
| Retrospective Studies | 85 | 2025 | 81768 | 0.730 |
Why?
|
| Polymorphism, Single Nucleotide | 22 | 2024 | 16027 | 0.720 |
Why?
|
| Kaplan-Meier Estimate | 18 | 2024 | 6541 | 0.720 |
Why?
|
| Mastectomy, Segmental | 6 | 2024 | 961 | 0.720 |
Why?
|
| Karyotyping | 13 | 2023 | 1173 | 0.710 |
Why?
|
| Apoptosis | 19 | 2020 | 9506 | 0.710 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2022 | 2056 | 0.710 |
Why?
|
| Neovascularization, Pathologic | 5 | 2024 | 2635 | 0.700 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 6 | 2022 | 631 | 0.690 |
Why?
|
| Midazolam | 2 | 2019 | 267 | 0.690 |
Why?
|
| Cyclophosphamide | 8 | 2020 | 2226 | 0.690 |
Why?
|
| Gene Expression Profiling | 21 | 2024 | 9508 | 0.690 |
Why?
|
| Treatment Outcome | 66 | 2025 | 65365 | 0.680 |
Why?
|
| Hepatitis B | 2 | 2023 | 707 | 0.680 |
Why?
|
| Hemoglobins, Abnormal | 2 | 2019 | 119 | 0.680 |
Why?
|
| Macrophages | 9 | 2024 | 5796 | 0.680 |
Why?
|
| Pregnancy | 52 | 2024 | 30198 | 0.680 |
Why?
|
| Craniotomy | 4 | 2020 | 747 | 0.670 |
Why?
|
| Aged, 80 and over | 53 | 2024 | 59683 | 0.660 |
Why?
|
| Flumazenil | 1 | 2019 | 84 | 0.660 |
Why?
|
| Angiopoietin-1 | 1 | 2019 | 122 | 0.650 |
Why?
|
| Sarcoma, Synovial | 1 | 2020 | 156 | 0.640 |
Why?
|
| Doxorubicin | 8 | 2020 | 2229 | 0.640 |
Why?
|
| Supratentorial Neoplasms | 2 | 2020 | 159 | 0.630 |
Why?
|
| Male | 143 | 2024 | 364870 | 0.630 |
Why?
|
| Serum Amyloid A Protein | 1 | 2018 | 128 | 0.620 |
Why?
|
| Steroids | 2 | 2014 | 936 | 0.620 |
Why?
|
| Antineoplastic Agents, Hormonal | 8 | 2021 | 1536 | 0.610 |
Why?
|
| Lymphatic Metastasis | 11 | 2021 | 2924 | 0.610 |
Why?
|
| Cholesterol, HDL | 2 | 2024 | 1820 | 0.610 |
Why?
|
| Cadherins | 3 | 2020 | 905 | 0.610 |
Why?
|
| Absorptiometry, Photon | 1 | 2024 | 1752 | 0.610 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2024 | 8628 | 0.600 |
Why?
|
| Animals | 83 | 2024 | 169322 | 0.600 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2019 | 623 | 0.600 |
Why?
|
| Epothilones | 2 | 2011 | 42 | 0.590 |
Why?
|
| Bone Density | 3 | 2024 | 3559 | 0.590 |
Why?
|
| Pyridines | 10 | 2024 | 2889 | 0.590 |
Why?
|
| Air Pollutants, Occupational | 1 | 2020 | 409 | 0.590 |
Why?
|
| Semantics | 3 | 2018 | 618 | 0.580 |
Why?
|
| Dolphins | 1 | 2017 | 14 | 0.580 |
Why?
|
| Carboplatin | 1 | 2020 | 799 | 0.580 |
Why?
|
| Aromatase Inhibitors | 4 | 2018 | 519 | 0.570 |
Why?
|
| Polyethylene Glycols | 4 | 2020 | 1195 | 0.570 |
Why?
|
| Sex Chromosome Aberrations | 6 | 2023 | 116 | 0.570 |
Why?
|
| Pregnancy Outcome | 6 | 2023 | 2961 | 0.570 |
Why?
|
| Plant Proteins | 3 | 2021 | 376 | 0.560 |
Why?
|
| Imagination | 1 | 2018 | 226 | 0.560 |
Why?
|
| Genetic Testing | 11 | 2024 | 3587 | 0.560 |
Why?
|
| Phenanthrenes | 2 | 2015 | 66 | 0.560 |
Why?
|
| alpha-Glucosidases | 1 | 2017 | 46 | 0.560 |
Why?
|
| Vinblastine | 2 | 2015 | 488 | 0.550 |
Why?
|
| Aneuploidy | 7 | 2023 | 572 | 0.550 |
Why?
|
| Molecular Targeted Therapy | 12 | 2020 | 2830 | 0.550 |
Why?
|
| Disease-Free Survival | 21 | 2023 | 6856 | 0.550 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2017 | 43 | 0.550 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2024 | 1105 | 0.550 |
Why?
|
| Theory of Mind | 1 | 2018 | 95 | 0.540 |
Why?
|
| Hippocampus | 4 | 2022 | 3784 | 0.540 |
Why?
|
| Anesthesia, General | 9 | 2021 | 1186 | 0.530 |
Why?
|
| Attitude | 2 | 2020 | 772 | 0.530 |
Why?
|
| Meningeal Neoplasms | 4 | 2023 | 1253 | 0.530 |
Why?
|
| Diterpenes | 2 | 2015 | 170 | 0.530 |
Why?
|
| Survival Rate | 27 | 2025 | 12870 | 0.530 |
Why?
|
| Genetic Pleiotropy | 1 | 2017 | 181 | 0.530 |
Why?
|
| Medication Systems, Hospital | 1 | 2017 | 154 | 0.530 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 597 | 0.530 |
Why?
|
| Drug Resistance, Neoplasm | 17 | 2024 | 5335 | 0.520 |
Why?
|
| Medical Oncology | 8 | 2022 | 2348 | 0.520 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 662 | 0.520 |
Why?
|
| Quinolines | 4 | 2022 | 768 | 0.520 |
Why?
|
| Pressure | 3 | 2018 | 1172 | 0.520 |
Why?
|
| Aquaporin 4 | 1 | 2017 | 161 | 0.510 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2021 | 493 | 0.510 |
Why?
|
| Carcinoma | 3 | 2021 | 2340 | 0.510 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2024 | 8198 | 0.510 |
Why?
|
| Pain | 2 | 2022 | 5102 | 0.510 |
Why?
|
| Qualitative Research | 2 | 2024 | 3131 | 0.510 |
Why?
|
| Phytoestrogens | 1 | 2015 | 59 | 0.500 |
Why?
|
| Genes, erbB-2 | 4 | 2011 | 162 | 0.500 |
Why?
|
| Mutation | 31 | 2024 | 30230 | 0.500 |
Why?
|
| Isoflurane | 2 | 2021 | 384 | 0.490 |
Why?
|
| Monocytes | 1 | 2024 | 2594 | 0.490 |
Why?
|
| MicroRNAs | 5 | 2024 | 3794 | 0.480 |
Why?
|
| Osteoporosis | 1 | 2024 | 1606 | 0.480 |
Why?
|
| Antipyretics | 1 | 2014 | 23 | 0.480 |
Why?
|
| Eligibility Determination | 2 | 2017 | 421 | 0.470 |
Why?
|
| Population Surveillance | 3 | 2016 | 2598 | 0.470 |
Why?
|
| Young Adult | 40 | 2023 | 60048 | 0.470 |
Why?
|
| Anesthetics, Inhalation | 4 | 2015 | 573 | 0.470 |
Why?
|
| Oxazoles | 3 | 2020 | 199 | 0.470 |
Why?
|
| RNA, Small Interfering | 5 | 2011 | 3436 | 0.470 |
Why?
|
| Leukemia | 1 | 2022 | 1526 | 0.460 |
Why?
|
| Mice, Inbred ICR | 3 | 2022 | 363 | 0.460 |
Why?
|
| Premature Birth | 2 | 2023 | 1814 | 0.460 |
Why?
|
| Gene Products, vpr | 2 | 2010 | 33 | 0.460 |
Why?
|
| Up-Regulation | 3 | 2020 | 4137 | 0.460 |
Why?
|
| Cinnamomum | 1 | 2013 | 1 | 0.460 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2010 | 595 | 0.450 |
Why?
|
| Databases, Genetic | 3 | 2020 | 1748 | 0.450 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2013 | 100 | 0.450 |
Why?
|
| Upper Extremity | 1 | 2019 | 684 | 0.450 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2017 | 1197 | 0.450 |
Why?
|
| Cell Proliferation | 16 | 2024 | 10464 | 0.450 |
Why?
|
| Neoplasms, Second Primary | 3 | 2022 | 1060 | 0.450 |
Why?
|
| Rats | 20 | 2024 | 23833 | 0.450 |
Why?
|
| Spinal Cord Injuries | 2 | 2018 | 929 | 0.440 |
Why?
|
| Intraoperative Awareness | 4 | 2015 | 8 | 0.440 |
Why?
|
| Lung Neoplasms | 15 | 2023 | 13576 | 0.440 |
Why?
|
| Systems Biology | 1 | 2017 | 479 | 0.440 |
Why?
|
| TRPM Cation Channels | 1 | 2014 | 139 | 0.440 |
Why?
|
| Body Temperature Regulation | 2 | 2014 | 292 | 0.440 |
Why?
|
| Camptothecin | 3 | 2024 | 593 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2020 | 2461 | 0.430 |
Why?
|
| Coffea | 1 | 2013 | 22 | 0.430 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2020 | 3794 | 0.430 |
Why?
|
| Piperazines | 6 | 2024 | 2552 | 0.430 |
Why?
|
| Cranial Irradiation | 3 | 2016 | 395 | 0.420 |
Why?
|
| Mice | 40 | 2024 | 82004 | 0.420 |
Why?
|
| Gene Expression Regulation, Plant | 3 | 2023 | 211 | 0.420 |
Why?
|
| Reactive Oxygen Species | 4 | 2017 | 2146 | 0.420 |
Why?
|
| Trisomy | 4 | 2024 | 260 | 0.420 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 1141 | 0.420 |
Why?
|
| Thiolester Hydrolases | 1 | 2013 | 91 | 0.420 |
Why?
|
| Diagnostic Imaging | 5 | 2020 | 3541 | 0.420 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 244 | 0.410 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 706 | 0.410 |
Why?
|
| Neuromyelitis Optica | 1 | 2017 | 266 | 0.410 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2014 | 1539 | 0.410 |
Why?
|
| Neonatal Screening | 2 | 2017 | 618 | 0.410 |
Why?
|
| Particulate Matter | 9 | 2021 | 2609 | 0.410 |
Why?
|
| Social Behavior | 2 | 2018 | 1146 | 0.410 |
Why?
|
| Cognition | 7 | 2021 | 7074 | 0.410 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2013 | 279 | 0.410 |
Why?
|
| Aminopyridines | 4 | 2021 | 580 | 0.400 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 864 | 0.400 |
Why?
|
| Neuroprotective Agents | 3 | 2019 | 957 | 0.400 |
Why?
|
| Delirium | 6 | 2021 | 1695 | 0.400 |
Why?
|
| Cell Line, Tumor | 29 | 2024 | 17132 | 0.400 |
Why?
|
| Collagen Type I | 1 | 2015 | 620 | 0.400 |
Why?
|
| Dentate Gyrus | 1 | 2013 | 165 | 0.400 |
Why?
|
| Sequence Analysis, DNA | 3 | 2020 | 4774 | 0.390 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 5422 | 0.390 |
Why?
|
| Hypnotics and Sedatives | 3 | 2019 | 1188 | 0.390 |
Why?
|
| Prospective Studies | 31 | 2024 | 54921 | 0.390 |
Why?
|
| Inhalation Exposure | 5 | 2022 | 431 | 0.390 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1428 | 0.390 |
Why?
|
| Quality of Life | 14 | 2024 | 13499 | 0.390 |
Why?
|
| Alkaloids | 1 | 2013 | 192 | 0.390 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 411 | 0.390 |
Why?
|
| Hepatitis B virus | 4 | 2023 | 527 | 0.390 |
Why?
|
| Estrogen Receptor alpha | 4 | 2020 | 580 | 0.380 |
Why?
|
| Osteonecrosis | 1 | 2013 | 230 | 0.380 |
Why?
|
| Neoadjuvant Therapy | 8 | 2024 | 2909 | 0.380 |
Why?
|
| Combined Modality Therapy | 10 | 2025 | 8562 | 0.380 |
Why?
|
| Gene Regulatory Networks | 3 | 2017 | 1753 | 0.380 |
Why?
|
| Polymerase Chain Reaction | 6 | 2023 | 6084 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2024 | 36849 | 0.380 |
Why?
|
| Phytotherapy | 1 | 2013 | 298 | 0.370 |
Why?
|
| Chromosome Deletion | 4 | 2024 | 1390 | 0.370 |
Why?
|
| Air Pollution | 5 | 2021 | 2363 | 0.370 |
Why?
|
| Protein Kinase C | 1 | 2016 | 1207 | 0.370 |
Why?
|
| Neutropenia | 1 | 2016 | 893 | 0.370 |
Why?
|
| Colitis | 2 | 2021 | 1244 | 0.370 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 4 | 2020 | 906 | 0.370 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 2 | 2022 | 13 | 0.370 |
Why?
|
| Terminal Care | 1 | 2023 | 1773 | 0.370 |
Why?
|
| Disease Models, Animal | 14 | 2024 | 18358 | 0.360 |
Why?
|
| Tissue Donors | 1 | 2020 | 2389 | 0.360 |
Why?
|
| Antioxidants | 3 | 2019 | 1673 | 0.360 |
Why?
|
| Leukocytes | 2 | 2017 | 2030 | 0.360 |
Why?
|
| Plant Extracts | 3 | 2017 | 497 | 0.360 |
Why?
|
| Tomography, Optical Coherence | 2 | 2023 | 2957 | 0.350 |
Why?
|
| Molecular Chaperones | 2 | 2012 | 762 | 0.350 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2022 | 1118 | 0.350 |
Why?
|
| Genotype | 19 | 2024 | 13038 | 0.350 |
Why?
|
| Benzothiazoles | 1 | 2011 | 248 | 0.350 |
Why?
|
| Monitoring, Intraoperative | 4 | 2020 | 950 | 0.340 |
Why?
|
| Bone Neoplasms | 2 | 2020 | 2565 | 0.340 |
Why?
|
| Neutrophils | 3 | 2021 | 3785 | 0.340 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2024 | 1767 | 0.330 |
Why?
|
| Uric Acid | 1 | 2016 | 806 | 0.330 |
Why?
|
| Fiber Optic Technology | 1 | 2011 | 291 | 0.330 |
Why?
|
| Survival Analysis | 15 | 2024 | 10117 | 0.330 |
Why?
|
| Brassica napus | 2 | 2019 | 5 | 0.330 |
Why?
|
| Household Articles | 2 | 2021 | 21 | 0.330 |
Why?
|
| Muscle Relaxation | 1 | 2009 | 138 | 0.330 |
Why?
|
| Random Allocation | 4 | 2020 | 2397 | 0.330 |
Why?
|
| Cohort Studies | 26 | 2024 | 41791 | 0.330 |
Why?
|
| Microglia | 1 | 2018 | 1374 | 0.330 |
Why?
|
| Pharyngeal Muscles | 1 | 2009 | 81 | 0.330 |
Why?
|
| Fluorouracil | 6 | 2014 | 1655 | 0.330 |
Why?
|
| Palate, Soft | 1 | 2009 | 100 | 0.330 |
Why?
|
| Proportional Hazards Models | 13 | 2023 | 12557 | 0.320 |
Why?
|
| Biofuels | 2 | 2023 | 46 | 0.320 |
Why?
|
| Biomedical Research | 3 | 2020 | 3464 | 0.320 |
Why?
|
| Capsules | 2 | 2020 | 193 | 0.320 |
Why?
|
| Models, Theoretical | 4 | 2018 | 3579 | 0.320 |
Why?
|
| Inflammatory Breast Neoplasms | 2 | 2022 | 154 | 0.320 |
Why?
|
| Cooking | 5 | 2021 | 312 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2024 | 18047 | 0.320 |
Why?
|
| Connexin 43 | 1 | 2010 | 202 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2020 | 3520 | 0.320 |
Why?
|
| Heterozygote | 5 | 2019 | 2792 | 0.310 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 378 | 0.310 |
Why?
|
| Disease Progression | 16 | 2023 | 13646 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2019 | 2911 | 0.310 |
Why?
|
| Abortion, Spontaneous | 2 | 2024 | 539 | 0.310 |
Why?
|
| Gene Deletion | 5 | 2021 | 2673 | 0.310 |
Why?
|
| Hydroxyl Radical | 2 | 2000 | 82 | 0.310 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2024 | 3666 | 0.310 |
Why?
|
| Spinal Cord | 3 | 2022 | 1813 | 0.310 |
Why?
|
| Follow-Up Studies | 27 | 2025 | 39405 | 0.300 |
Why?
|
| Germ-Line Mutation | 4 | 2023 | 1885 | 0.300 |
Why?
|
| Fever | 2 | 2021 | 1620 | 0.300 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 905 | 0.300 |
Why?
|
| Brain | 13 | 2024 | 27452 | 0.300 |
Why?
|
| Morpholines | 4 | 2020 | 584 | 0.300 |
Why?
|
| Electroencephalography | 9 | 2022 | 6317 | 0.300 |
Why?
|
| Cyclin-Dependent Kinase 4 | 6 | 2024 | 566 | 0.300 |
Why?
|
| Autoantibodies | 1 | 2017 | 2126 | 0.300 |
Why?
|
| Infant | 15 | 2023 | 36512 | 0.290 |
Why?
|
| beta-Globins | 2 | 2021 | 112 | 0.290 |
Why?
|
| Computational Biology | 4 | 2019 | 3541 | 0.290 |
Why?
|
| Synapses | 2 | 2015 | 1766 | 0.290 |
Why?
|
| Deoxycytidine | 4 | 2014 | 887 | 0.280 |
Why?
|
| Neural Pathways | 1 | 2018 | 3121 | 0.280 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2020 | 957 | 0.280 |
Why?
|
| Taxoids | 3 | 2022 | 668 | 0.280 |
Why?
|
| Organometallic Compounds | 2 | 2023 | 648 | 0.280 |
Why?
|
| Soil | 2 | 2024 | 118 | 0.280 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2024 | 755 | 0.280 |
Why?
|
| Peptides | 3 | 2015 | 4352 | 0.280 |
Why?
|
| Risk Factors | 33 | 2024 | 74954 | 0.280 |
Why?
|
| Neuronal Plasticity | 2 | 2013 | 1448 | 0.270 |
Why?
|
| Technology, Pharmaceutical | 2 | 2005 | 84 | 0.270 |
Why?
|
| Retinoblastoma Binding Proteins | 2 | 2024 | 102 | 0.270 |
Why?
|
| Mice, Nude | 7 | 2021 | 3630 | 0.270 |
Why?
|
| Wind | 2 | 2024 | 44 | 0.270 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2020 | 10377 | 0.270 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2020 | 1891 | 0.270 |
Why?
|
| Immunohistochemistry | 12 | 2024 | 11117 | 0.270 |
Why?
|
| Drug Eruptions | 1 | 2009 | 336 | 0.270 |
Why?
|
| Contrast Media | 7 | 2023 | 5337 | 0.270 |
Why?
|
| Vision Disparity | 1 | 2006 | 29 | 0.260 |
Why?
|
| Drug Therapy, Combination | 4 | 2020 | 6319 | 0.260 |
Why?
|
| Research | 2 | 2017 | 1981 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2022 | 10776 | 0.260 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 2923 | 0.260 |
Why?
|
| Synovial Membrane | 2 | 2019 | 535 | 0.260 |
Why?
|
| Case-Control Studies | 14 | 2020 | 22292 | 0.260 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 891 | 0.260 |
Why?
|
| Logistic Models | 9 | 2024 | 13323 | 0.260 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2024 | 2524 | 0.250 |
Why?
|
| Parents | 4 | 2023 | 3596 | 0.250 |
Why?
|
| Patient Participation | 3 | 2017 | 1448 | 0.250 |
Why?
|
| Coal | 5 | 2021 | 122 | 0.250 |
Why?
|
| Thailand | 2 | 2016 | 288 | 0.250 |
Why?
|
| Neurosurgical Procedures | 2 | 2016 | 2097 | 0.250 |
Why?
|
| Depth Perception | 1 | 2006 | 95 | 0.250 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 3921 | 0.250 |
Why?
|
| Signal Transduction | 15 | 2023 | 23629 | 0.250 |
Why?
|
| Thalassemia | 2 | 2021 | 267 | 0.250 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 1664 | 0.250 |
Why?
|
| Exotropia | 1 | 2006 | 64 | 0.250 |
Why?
|
| Anesthetics, General | 2 | 2019 | 152 | 0.240 |
Why?
|
| Fetal Diseases | 2 | 2020 | 916 | 0.240 |
Why?
|
| Consciousness Monitors | 6 | 2016 | 21 | 0.240 |
Why?
|
| Genomics | 9 | 2024 | 5916 | 0.240 |
Why?
|
| Oxidative Stress | 5 | 2020 | 3139 | 0.240 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2014 | 2678 | 0.240 |
Why?
|
| Rats, Inbred SHR | 1 | 2024 | 186 | 0.240 |
Why?
|
| Child | 22 | 2024 | 80894 | 0.240 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 4570 | 0.240 |
Why?
|
| Reproducibility of Results | 12 | 2024 | 20224 | 0.240 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2024 | 523 | 0.230 |
Why?
|
| Feminine Hygiene Products | 2 | 2021 | 3 | 0.230 |
Why?
|
| Tumor Microenvironment | 6 | 2024 | 3940 | 0.230 |
Why?
|
| Sequence Deletion | 3 | 2018 | 1496 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2020 | 3616 | 0.230 |
Why?
|
| DNA Methylation | 5 | 2022 | 4419 | 0.230 |
Why?
|
| Dexmedetomidine | 2 | 2021 | 320 | 0.230 |
Why?
|
| Electron Transport Complex IV | 2 | 2014 | 192 | 0.230 |
Why?
|
| Patient Selection | 5 | 2020 | 4265 | 0.230 |
Why?
|
| Multigene Family | 3 | 2023 | 1082 | 0.230 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 5830 | 0.230 |
Why?
|
| Ovarian Neoplasms | 5 | 2021 | 4908 | 0.230 |
Why?
|
| Referral and Consultation | 6 | 2020 | 3627 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 8 | 2013 | 9261 | 0.230 |
Why?
|
| Metals, Heavy | 1 | 2005 | 149 | 0.230 |
Why?
|
| Linear Models | 6 | 2020 | 5878 | 0.230 |
Why?
|
| Dioctyl Sulfosuccinic Acid | 1 | 2023 | 8 | 0.230 |
Why?
|
| Intubation, Intratracheal | 2 | 2011 | 1359 | 0.230 |
Why?
|
| Alleles | 9 | 2023 | 6892 | 0.220 |
Why?
|
| Receptors, Androgen | 3 | 2024 | 1083 | 0.220 |
Why?
|
| Depression | 4 | 2017 | 8241 | 0.220 |
Why?
|
| Microarray Analysis | 3 | 2021 | 753 | 0.220 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 873 | 0.220 |
Why?
|
| Inflammation | 3 | 2022 | 10863 | 0.220 |
Why?
|
| Sorghum | 1 | 2023 | 6 | 0.220 |
Why?
|
| Muscles | 2 | 2022 | 1582 | 0.220 |
Why?
|
| Anesthesia Recovery Period | 3 | 2021 | 155 | 0.220 |
Why?
|
| Melanoma | 5 | 2023 | 5705 | 0.220 |
Why?
|
| Lymph Nodes | 5 | 2021 | 3471 | 0.220 |
Why?
|
| Alkanes | 1 | 2023 | 39 | 0.220 |
Why?
|
| Multicystic Dysplastic Kidney | 1 | 2023 | 7 | 0.220 |
Why?
|
| DNA, Neoplasm | 4 | 2017 | 1748 | 0.220 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2019 | 2060 | 0.220 |
Why?
|
| Femur | 2 | 2023 | 1311 | 0.220 |
Why?
|
| Kidney Neoplasms | 4 | 2018 | 4301 | 0.220 |
Why?
|
| Algorithms | 8 | 2021 | 14154 | 0.220 |
Why?
|
| Saccharum | 1 | 2023 | 20 | 0.220 |
Why?
|
| Histocytochemistry | 1 | 2024 | 699 | 0.220 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 948 | 0.210 |
Why?
|
| Liver | 6 | 2019 | 7570 | 0.210 |
Why?
|
| Mammography | 5 | 2022 | 2434 | 0.210 |
Why?
|
| Nitriles | 2 | 2014 | 984 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2024 | 344 | 0.210 |
Why?
|
| Erythrocytes | 1 | 2012 | 2421 | 0.210 |
Why?
|
| Adolescent | 28 | 2024 | 89182 | 0.210 |
Why?
|
| Triazoles | 2 | 2014 | 904 | 0.210 |
Why?
|
| Benzene | 1 | 2023 | 106 | 0.210 |
Why?
|
| Positron-Emission Tomography | 7 | 2022 | 6670 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3587 | 0.210 |
Why?
|
| Lymphangioma, Cystic | 1 | 2022 | 34 | 0.210 |
Why?
|
| Clubfoot | 1 | 2023 | 87 | 0.210 |
Why?
|
| Adenoviridae | 4 | 2010 | 1093 | 0.210 |
Why?
|
| Multivariate Analysis | 10 | 2021 | 12092 | 0.210 |
Why?
|
| Models, Statistical | 1 | 2017 | 5099 | 0.210 |
Why?
|
| Inhibin-beta Subunits | 1 | 2022 | 27 | 0.210 |
Why?
|
| Nomograms | 1 | 2024 | 236 | 0.210 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2023 | 936 | 0.210 |
Why?
|
| Osteopontin | 1 | 2024 | 306 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2024 | 123 | 0.210 |
Why?
|
| Turner Syndrome | 1 | 2024 | 130 | 0.200 |
Why?
|
| Postoperative Complications | 8 | 2021 | 15854 | 0.200 |
Why?
|
| Uniparental Disomy | 1 | 2022 | 46 | 0.200 |
Why?
|
| Receptor, erbB-3 | 1 | 2023 | 142 | 0.200 |
Why?
|
| Ventilation | 2 | 2020 | 129 | 0.200 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2022 | 75 | 0.200 |
Why?
|
| Androstadienes | 1 | 2024 | 348 | 0.200 |
Why?
|
| Chemokine CCL3 | 1 | 2022 | 85 | 0.200 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2022 | 125 | 0.200 |
Why?
|
| Dioxanes | 1 | 2022 | 36 | 0.200 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2018 | 383 | 0.200 |
Why?
|
| Insecticides | 1 | 2024 | 200 | 0.200 |
Why?
|
| Meglumine | 2 | 2023 | 144 | 0.200 |
Why?
|
| Gene Dosage | 3 | 2024 | 1221 | 0.200 |
Why?
|
| Memantine | 1 | 2023 | 111 | 0.200 |
Why?
|
| Siblings | 2 | 2023 | 829 | 0.200 |
Why?
|
| Metals | 3 | 2014 | 713 | 0.190 |
Why?
|
| Scoliosis | 2 | 2019 | 793 | 0.190 |
Why?
|
| Mammaplasty | 3 | 2016 | 1263 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2022 | 122 | 0.190 |
Why?
|
| Sentinel Lymph Node Biopsy | 3 | 2023 | 740 | 0.190 |
Why?
|
| Predictive Value of Tests | 14 | 2024 | 15455 | 0.190 |
Why?
|
| Electrons | 1 | 2023 | 264 | 0.190 |
Why?
|
| Palliative Care | 4 | 2023 | 3643 | 0.190 |
Why?
|
| Phthalazines | 2 | 2023 | 397 | 0.190 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2017 | 3620 | 0.190 |
Why?
|
| Alberta | 1 | 2021 | 67 | 0.190 |
Why?
|
| Concept Formation | 1 | 2022 | 161 | 0.190 |
Why?
|
| Preimplantation Diagnosis | 1 | 2023 | 143 | 0.190 |
Why?
|
| Death | 2 | 2023 | 683 | 0.190 |
Why?
|
| Asthenopia | 1 | 2021 | 12 | 0.190 |
Why?
|
| Prevalence | 14 | 2024 | 15868 | 0.190 |
Why?
|
| Salvia | 1 | 2021 | 13 | 0.190 |
Why?
|
| Confusion | 2 | 2021 | 278 | 0.190 |
Why?
|
| Stress, Physiological | 2 | 2019 | 1410 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2019 | 2884 | 0.190 |
Why?
|
| Awareness | 3 | 2019 | 653 | 0.190 |
Why?
|
| Transcription Factors | 7 | 2023 | 12166 | 0.190 |
Why?
|
| Preoperative Period | 3 | 2020 | 563 | 0.190 |
Why?
|
| Carcinogens | 1 | 2023 | 455 | 0.190 |
Why?
|
| Social Support | 2 | 2022 | 2190 | 0.190 |
Why?
|
| Gases | 1 | 2022 | 204 | 0.190 |
Why?
|
| Glycine | 1 | 2024 | 672 | 0.190 |
Why?
|
| Drugs, Investigational | 1 | 2003 | 213 | 0.180 |
Why?
|
| Cognition Disorders | 3 | 2014 | 3985 | 0.180 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 1764 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2021 | 354 | 0.180 |
Why?
|
| Infant, Newborn | 12 | 2023 | 26410 | 0.180 |
Why?
|
| Gadolinium DTPA | 2 | 2023 | 823 | 0.180 |
Why?
|
| Cordocentesis | 1 | 2020 | 10 | 0.180 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 2020 | 17 | 0.180 |
Why?
|
| Fatty Acid Desaturases | 1 | 2021 | 102 | 0.180 |
Why?
|
| Premedication | 1 | 2021 | 246 | 0.180 |
Why?
|
| Pyrimidine Nucleotides | 1 | 2000 | 7 | 0.180 |
Why?
|
| Time Factors | 14 | 2024 | 40267 | 0.180 |
Why?
|
| Wood | 3 | 2016 | 92 | 0.180 |
Why?
|
| Phenotype | 11 | 2023 | 16716 | 0.180 |
Why?
|
| Disease Management | 4 | 2025 | 2536 | 0.180 |
Why?
|
| Surgical Flaps | 1 | 2009 | 1682 | 0.180 |
Why?
|
| Pathology, Clinical | 1 | 2024 | 376 | 0.180 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2020 | 25 | 0.180 |
Why?
|
| Pyrimidines | 2 | 2022 | 3048 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 20766 | 0.180 |
Why?
|
| Drug Design | 4 | 2012 | 1046 | 0.180 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 11220 | 0.180 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2000 | 30 | 0.180 |
Why?
|
| Ichthyosis, X-Linked | 1 | 2020 | 1 | 0.180 |
Why?
|
| Ecosystem | 1 | 2024 | 494 | 0.180 |
Why?
|
| Ketamine | 2 | 2022 | 524 | 0.170 |
Why?
|
| Steryl-Sulfatase | 1 | 2020 | 11 | 0.170 |
Why?
|
| Cornea | 2 | 2023 | 1314 | 0.170 |
Why?
|
| Maternal Age | 1 | 2023 | 809 | 0.170 |
Why?
|
| Heart Failure | 3 | 2013 | 11860 | 0.170 |
Why?
|
| Epidermal Growth Factor | 2 | 2021 | 698 | 0.170 |
Why?
|
| Mesangial Cells | 1 | 2020 | 23 | 0.170 |
Why?
|
| Ghana | 1 | 2021 | 319 | 0.170 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2017 | 1931 | 0.170 |
Why?
|
| Ginsenosides | 2 | 2009 | 12 | 0.170 |
Why?
|
| Freund's Adjuvant | 1 | 2020 | 144 | 0.170 |
Why?
|
| Plant Diseases | 1 | 2021 | 184 | 0.170 |
Why?
|
| Tracheal Stenosis | 1 | 2022 | 228 | 0.170 |
Why?
|
| Incidence | 15 | 2023 | 21544 | 0.170 |
Why?
|
| Riboflavin | 1 | 2000 | 107 | 0.170 |
Why?
|
| Respiratory Therapy | 1 | 2020 | 125 | 0.170 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 3609 | 0.170 |
Why?
|
| Registries | 8 | 2023 | 8378 | 0.170 |
Why?
|
| Cancer Care Facilities | 2 | 2020 | 424 | 0.170 |
Why?
|
| Angiotensin I | 1 | 2019 | 48 | 0.170 |
Why?
|
| Laccase | 1 | 2019 | 8 | 0.170 |
Why?
|
| Consensus | 6 | 2022 | 3212 | 0.170 |
Why?
|
| Amoxicillin | 1 | 2021 | 182 | 0.170 |
Why?
|
| Indocyanine Green | 1 | 2021 | 238 | 0.170 |
Why?
|
| Double-Blind Method | 7 | 2024 | 12457 | 0.170 |
Why?
|
| Radiopharmaceuticals | 3 | 2022 | 2734 | 0.170 |
Why?
|
| Gingivitis | 1 | 2020 | 125 | 0.170 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1674 | 0.170 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 1673 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 6 | 2022 | 7453 | 0.160 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2022 | 290 | 0.160 |
Why?
|
| Cell Nucleus | 5 | 2020 | 2887 | 0.160 |
Why?
|
| Oxygen | 4 | 2018 | 4273 | 0.160 |
Why?
|
| Radiotherapy, Adjuvant | 5 | 2016 | 1794 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 50 | 0.160 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2020 | 259 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2012 | 325 | 0.160 |
Why?
|
| GABA Modulators | 1 | 2019 | 109 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2019 | 2433 | 0.160 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2020 | 213 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 375 | 0.160 |
Why?
|
| Coloring Agents | 1 | 2021 | 563 | 0.160 |
Why?
|
| Hepatitis E | 1 | 2020 | 76 | 0.160 |
Why?
|
| Cyclin E | 1 | 2019 | 156 | 0.160 |
Why?
|
| Ligation | 2 | 2018 | 445 | 0.160 |
Why?
|
| Stomach Neoplasms | 2 | 2021 | 1481 | 0.160 |
Why?
|
| Genome, Plant | 1 | 2019 | 84 | 0.160 |
Why?
|
| Endpoint Determination | 3 | 2018 | 594 | 0.160 |
Why?
|
| Formaldehyde | 1 | 2020 | 361 | 0.160 |
Why?
|
| Housing | 4 | 2016 | 680 | 0.160 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2022 | 484 | 0.160 |
Why?
|
| Cytokines | 4 | 2021 | 7443 | 0.160 |
Why?
|
| Acclimatization | 1 | 2019 | 114 | 0.160 |
Why?
|
| United States | 22 | 2024 | 73144 | 0.160 |
Why?
|
| Blood Donors | 1 | 2020 | 344 | 0.150 |
Why?
|
| Collagen Type II | 1 | 2019 | 151 | 0.150 |
Why?
|
| Drosophila Proteins | 3 | 2014 | 1713 | 0.150 |
Why?
|
| Benzimidazoles | 2 | 2021 | 864 | 0.150 |
Why?
|
| Lipid Peroxidation | 1 | 2019 | 276 | 0.150 |
Why?
|
| Positive-Pressure Respiration | 2 | 2020 | 713 | 0.150 |
Why?
|
| Fetal Proteins | 1 | 2018 | 99 | 0.150 |
Why?
|
| Neoplasm, Residual | 2 | 2022 | 1019 | 0.150 |
Why?
|
| Area Under Curve | 2 | 2021 | 1642 | 0.150 |
Why?
|
| Gene Frequency | 5 | 2023 | 3615 | 0.150 |
Why?
|
| End Stage Liver Disease | 1 | 2023 | 370 | 0.150 |
Why?
|
| Hemoglobinopathies | 1 | 2019 | 101 | 0.150 |
Why?
|
| Academies and Institutes | 1 | 2020 | 326 | 0.150 |
Why?
|
| Lipopolysaccharides | 2 | 2022 | 2215 | 0.150 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2019 | 281 | 0.150 |
Why?
|
| Pattern Recognition, Automated | 1 | 2024 | 998 | 0.150 |
Why?
|
| Down-Regulation | 6 | 2012 | 2937 | 0.150 |
Why?
|
| Genome, Human | 3 | 2023 | 4450 | 0.150 |
Why?
|
| Oncogene Proteins | 2 | 2019 | 718 | 0.150 |
Why?
|
| Alisma | 1 | 2017 | 1 | 0.150 |
Why?
|
| Rhizome | 1 | 2017 | 8 | 0.150 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11515 | 0.150 |
Why?
|
| Drug Hypersensitivity | 1 | 2007 | 923 | 0.150 |
Why?
|
| Kynurenic Acid | 1 | 2017 | 44 | 0.150 |
Why?
|
| Fetal Growth Retardation | 1 | 2022 | 591 | 0.150 |
Why?
|
| Arginase | 1 | 2018 | 81 | 0.150 |
Why?
|
| Subacute Care | 1 | 2020 | 188 | 0.150 |
Why?
|
| Sex Chromosomes | 3 | 2023 | 101 | 0.150 |
Why?
|
| Placenta | 2 | 2024 | 1722 | 0.150 |
Why?
|
| Polyamines | 1 | 2018 | 133 | 0.140 |
Why?
|
| Hyperalgesia | 1 | 2022 | 527 | 0.140 |
Why?
|
| Cell Movement | 5 | 2022 | 5214 | 0.140 |
Why?
|
| Societies, Medical | 4 | 2020 | 3960 | 0.140 |
Why?
|
| Consciousness | 2 | 2021 | 602 | 0.140 |
Why?
|
| Indole Alkaloids | 1 | 2017 | 23 | 0.140 |
Why?
|
| Tumor Burden | 4 | 2017 | 1913 | 0.140 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2017 | 54 | 0.140 |
Why?
|
| Postmenopause | 5 | 2021 | 2518 | 0.140 |
Why?
|
| U937 Cells | 1 | 2017 | 260 | 0.140 |
Why?
|
| Chondrosarcoma | 1 | 2020 | 306 | 0.140 |
Why?
|
| Maze Learning | 3 | 2015 | 484 | 0.140 |
Why?
|
| Electroconvulsive Therapy | 1 | 2022 | 502 | 0.140 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2020 | 410 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 12239 | 0.140 |
Why?
|
| Triterpenes | 1 | 2017 | 78 | 0.140 |
Why?
|
| Eye Proteins | 1 | 2020 | 628 | 0.140 |
Why?
|
| Receptors, Calcitriol | 2 | 1997 | 361 | 0.140 |
Why?
|
| Rare Diseases | 1 | 2022 | 630 | 0.140 |
Why?
|
| Posterior Horn Cells | 1 | 2017 | 87 | 0.140 |
Why?
|
| Rotavirus Infections | 1 | 2018 | 85 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 4 | 2020 | 6132 | 0.140 |
Why?
|
| Kynurenine | 1 | 2017 | 142 | 0.140 |
Why?
|
| Survivors | 5 | 2022 | 2382 | 0.140 |
Why?
|
| Astrocytoma | 1 | 2021 | 780 | 0.140 |
Why?
|
| Thoracic Injuries | 1 | 2019 | 288 | 0.140 |
Why?
|
| Virus Activation | 1 | 2019 | 322 | 0.140 |
Why?
|
| Lymphedema | 1 | 2023 | 527 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 365 | 0.140 |
Why?
|
| Nitrogen | 2 | 2016 | 345 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2022 | 885 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1628 | 0.140 |
Why?
|
| Particle Size | 6 | 2017 | 1653 | 0.140 |
Why?
|
| Tranexamic Acid | 1 | 2019 | 174 | 0.140 |
Why?
|
| beta Catenin | 2 | 2012 | 1047 | 0.140 |
Why?
|
| Insurance Carriers | 1 | 2018 | 159 | 0.130 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 295 | 0.130 |
Why?
|
| Hypophosphatemia, Familial | 1 | 1996 | 32 | 0.130 |
Why?
|
| Endothelium, Corneal | 2 | 1989 | 212 | 0.130 |
Why?
|
| Quality Control | 1 | 2019 | 833 | 0.130 |
Why?
|
| Aging | 4 | 2020 | 8764 | 0.130 |
Why?
|
| Hyperglycemia | 2 | 2022 | 1389 | 0.130 |
Why?
|
| Anilides | 1 | 2019 | 414 | 0.130 |
Why?
|
| Metabolome | 1 | 2023 | 1008 | 0.130 |
Why?
|
| Electrodes | 2 | 2023 | 617 | 0.130 |
Why?
|
| Geologic Sediments | 1 | 2016 | 81 | 0.130 |
Why?
|
| Kyphosis | 1 | 2019 | 253 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2024 | 2740 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 9063 | 0.130 |
Why?
|
| Pneumothorax | 1 | 2019 | 393 | 0.130 |
Why?
|
| Phenylurea Compounds | 1 | 2019 | 529 | 0.130 |
Why?
|
| Child, Preschool | 9 | 2023 | 42654 | 0.130 |
Why?
|
| Food Contamination | 2 | 2014 | 193 | 0.130 |
Why?
|
| Brain Damage, Chronic | 1 | 2017 | 267 | 0.130 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 289 | 0.130 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 669 | 0.130 |
Why?
|
| Comprehensive Health Care | 1 | 2016 | 123 | 0.130 |
Why?
|
| K562 Cells | 1 | 2017 | 637 | 0.130 |
Why?
|
| Genetic Association Studies | 4 | 2022 | 2741 | 0.130 |
Why?
|
| Hydroxamic Acids | 1 | 2018 | 482 | 0.130 |
Why?
|
| Acetamides | 1 | 2017 | 260 | 0.130 |
Why?
|
| Virus Replication | 1 | 2023 | 2458 | 0.130 |
Why?
|
| Micronutrients | 1 | 2019 | 390 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 2023 | 1424 | 0.130 |
Why?
|
| Lithium | 1 | 2019 | 600 | 0.130 |
Why?
|
| Adjustment Disorders | 1 | 1995 | 68 | 0.130 |
Why?
|
| Erythrocyte Indices | 1 | 2016 | 143 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2017 | 246 | 0.130 |
Why?
|
| Environmental Exposure | 3 | 2016 | 4528 | 0.130 |
Why?
|
| Radiotherapy | 3 | 2016 | 1509 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 708 | 0.120 |
Why?
|
| Cordyceps | 1 | 2015 | 2 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2020 | 540 | 0.120 |
Why?
|
| Bone Screws | 1 | 2019 | 534 | 0.120 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 1378 | 0.120 |
Why?
|
| Disease Susceptibility | 3 | 2019 | 1795 | 0.120 |
Why?
|
| Hepatectomy | 1 | 2019 | 588 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 6 | 2016 | 3631 | 0.120 |
Why?
|
| Clinical Trials, Phase III as Topic | 2 | 2012 | 876 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2021 | 937 | 0.120 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2015 | 25 | 0.120 |
Why?
|
| Metabolomics | 1 | 2024 | 1675 | 0.120 |
Why?
|
| Phylogeny | 3 | 2023 | 2842 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2018 | 1078 | 0.120 |
Why?
|
| Free Radical Scavengers | 1 | 1996 | 213 | 0.120 |
Why?
|
| Anticarcinogenic Agents | 2 | 2009 | 251 | 0.120 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 642 | 0.120 |
Why?
|
| DNA | 3 | 2017 | 7211 | 0.120 |
Why?
|
| Acupuncture Therapy | 1 | 2019 | 486 | 0.120 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2014 | 395 | 0.120 |
Why?
|
| Data Mining | 1 | 2020 | 560 | 0.120 |
Why?
|
| Ultrasonography | 4 | 2023 | 6001 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2014 | 2855 | 0.120 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2015 | 73 | 0.120 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 393 | 0.120 |
Why?
|
| Rural Population | 5 | 2017 | 2318 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2020 | 6238 | 0.120 |
Why?
|
| Liver Cirrhosis | 3 | 2023 | 1957 | 0.120 |
Why?
|
| Cross-Sectional Studies | 9 | 2024 | 26373 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2018 | 417 | 0.120 |
Why?
|
| Cesarean Section | 1 | 2023 | 1417 | 0.120 |
Why?
|
| Spores, Fungal | 1 | 2015 | 90 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2016 | 8326 | 0.120 |
Why?
|
| Age Factors | 11 | 2019 | 18472 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 5890 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2022 | 1180 | 0.120 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2023 | 339 | 0.120 |
Why?
|
| Single-Blind Method | 2 | 2016 | 1585 | 0.120 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 946 | 0.120 |
Why?
|
| Heart Defects, Congenital | 2 | 2022 | 4713 | 0.120 |
Why?
|
| Hair Color | 1 | 2015 | 131 | 0.120 |
Why?
|
| Fourier Analysis | 1 | 2015 | 440 | 0.120 |
Why?
|
| Phosphorus | 1 | 2015 | 336 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 3722 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11914 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2021 | 2750 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2023 | 1301 | 0.120 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2014 | 49 | 0.120 |
Why?
|
| Ultrasonography, Mammary | 1 | 2016 | 241 | 0.120 |
Why?
|
| Diuretics | 1 | 2017 | 612 | 0.110 |
Why?
|
| Chondroitin Sulfates | 1 | 2014 | 174 | 0.110 |
Why?
|
| RNA, Messenger | 8 | 2021 | 12801 | 0.110 |
Why?
|
| Hydrocephalus | 1 | 2021 | 770 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 2 | 2012 | 1727 | 0.110 |
Why?
|
| Glucose | 4 | 2017 | 4354 | 0.110 |
Why?
|
| Propofol | 1 | 2020 | 608 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 1 | 2024 | 1252 | 0.110 |
Why?
|
| Mosaicism | 3 | 2022 | 481 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 178 | 0.110 |
Why?
|
| Benzamides | 2 | 2014 | 1380 | 0.110 |
Why?
|
| Immunotherapy | 5 | 2022 | 4740 | 0.110 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2014 | 77 | 0.110 |
Why?
|
| Automobiles | 1 | 2014 | 112 | 0.110 |
Why?
|
| Quality of Health Care | 2 | 2023 | 4339 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 1112 | 0.110 |
Why?
|
| Acyl Carrier Protein | 1 | 2013 | 24 | 0.110 |
Why?
|
| Drainage | 1 | 2019 | 1183 | 0.110 |
Why?
|
| Memory, Long-Term | 1 | 2014 | 61 | 0.110 |
Why?
|
| Gyrus Cinguli | 2 | 2017 | 1137 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 1020 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2010 | 4069 | 0.110 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 3707 | 0.110 |
Why?
|
| RNA | 4 | 2010 | 2726 | 0.110 |
Why?
|
| Plants, Genetically Modified | 1 | 2013 | 115 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 22355 | 0.110 |
Why?
|
| Fossil Fuels | 1 | 2014 | 53 | 0.110 |
Why?
|
| Drosophila melanogaster | 2 | 2014 | 1723 | 0.110 |
Why?
|
| Family Characteristics | 2 | 2017 | 1003 | 0.110 |
Why?
|
| Melatonin | 1 | 2019 | 669 | 0.110 |
Why?
|
| Resuscitation | 1 | 2018 | 679 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 4647 | 0.110 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1900 | 0.110 |
Why?
|
| Neoplasm Transplantation | 3 | 2016 | 2017 | 0.110 |
Why?
|
| Equipment Design | 2 | 2019 | 3529 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 716 | 0.110 |
Why?
|
| Cosmetics | 1 | 2014 | 102 | 0.110 |
Why?
|
| Administration, Oral | 3 | 2019 | 4043 | 0.110 |
Why?
|
| Motor Cortex | 1 | 2021 | 1014 | 0.110 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2014 | 123 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2020 | 3101 | 0.110 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 3457 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 839 | 0.110 |
Why?
|
| Indoles | 2 | 2018 | 1825 | 0.110 |
Why?
|
| Proteomics | 2 | 2024 | 3906 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 780 | 0.110 |
Why?
|
| Pain Threshold | 1 | 2017 | 606 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 596 | 0.110 |
Why?
|
| Ovariectomy | 1 | 2015 | 615 | 0.110 |
Why?
|
| Drug Contamination | 1 | 2014 | 151 | 0.110 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2014 | 121 | 0.110 |
Why?
|
| Nanoparticles | 2 | 2015 | 1986 | 0.110 |
Why?
|
| Cloning, Molecular | 2 | 2021 | 4168 | 0.110 |
Why?
|
| Gene Expression | 3 | 2017 | 7595 | 0.110 |
Why?
|
| Nanowires | 1 | 2013 | 31 | 0.110 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 2236 | 0.110 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 1765 | 0.110 |
Why?
|
| Ephrin-B2 | 1 | 2012 | 40 | 0.110 |
Why?
|
| Plant Leaves | 1 | 2013 | 153 | 0.110 |
Why?
|
| Genetic Loci | 2 | 2020 | 2630 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2533 | 0.100 |
Why?
|
| Biological Products | 1 | 2022 | 934 | 0.100 |
Why?
|
| Databases, Factual | 4 | 2021 | 8072 | 0.100 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 310 | 0.100 |
Why?
|
| Cost Savings | 1 | 2018 | 915 | 0.100 |
Why?
|
| Antimetabolites | 1 | 2013 | 129 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2019 | 774 | 0.100 |
Why?
|
| Refractometry | 1 | 2013 | 57 | 0.100 |
Why?
|
| Risk | 5 | 2020 | 9635 | 0.100 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 198 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2017 | 1684 | 0.100 |
Why?
|
| Receptor, EphB4 | 1 | 2012 | 39 | 0.100 |
Why?
|
| Microwaves | 1 | 2014 | 184 | 0.100 |
Why?
|
| Soot | 1 | 2014 | 221 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2023 | 3526 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2018 | 1339 | 0.100 |
Why?
|
| Berberine | 1 | 2012 | 26 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1408 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1397 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3118 | 0.100 |
Why?
|
| Fentanyl | 1 | 2016 | 450 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2022 | 1252 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2021 | 13425 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 1492 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2017 | 1131 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2017 | 1093 | 0.100 |
Why?
|
| Ventricular Function, Left | 3 | 2022 | 3942 | 0.100 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2014 | 321 | 0.100 |
Why?
|
| Gene Library | 2 | 2013 | 1061 | 0.100 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2014 | 394 | 0.100 |
Why?
|
| Recombinant Proteins | 5 | 2010 | 6512 | 0.100 |
Why?
|
| Genetic Counseling | 1 | 2016 | 634 | 0.100 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 986 | 0.100 |
Why?
|
| Decision Making | 3 | 2019 | 3953 | 0.100 |
Why?
|
| Renal Dialysis | 2 | 2019 | 1802 | 0.100 |
Why?
|
| Lipase | 1 | 2014 | 321 | 0.100 |
Why?
|
| Pilot Projects | 8 | 2021 | 8730 | 0.100 |
Why?
|
| Executive Function | 2 | 2018 | 1405 | 0.100 |
Why?
|
| Cross-Cultural Comparison | 1 | 1995 | 638 | 0.100 |
Why?
|
| Comorbidity | 7 | 2019 | 10588 | 0.100 |
Why?
|
| Down Syndrome | 1 | 2020 | 915 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 1468 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2014 | 1666 | 0.100 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4120 | 0.100 |
Why?
|
| Iontophoresis | 1 | 2012 | 75 | 0.100 |
Why?
|
| Quality Improvement | 3 | 2023 | 3858 | 0.100 |
Why?
|
| Workflow | 1 | 2017 | 859 | 0.100 |
Why?
|
| Drug Synergism | 2 | 2019 | 1760 | 0.100 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 1150 | 0.100 |
Why?
|
| Dust | 1 | 2014 | 488 | 0.100 |
Why?
|
| Self-Assessment | 1 | 2014 | 401 | 0.100 |
Why?
|
| Radionuclide Imaging | 2 | 2013 | 1998 | 0.100 |
Why?
|
| Sweat | 1 | 2012 | 57 | 0.100 |
Why?
|
| DNA, Complementary | 2 | 2013 | 1992 | 0.100 |
Why?
|
| Maternal Exposure | 1 | 2019 | 1079 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 1855 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2022 | 14481 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2018 | 4286 | 0.100 |
Why?
|
| Epiglottis | 1 | 2011 | 81 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2014 | 597 | 0.100 |
Why?
|
| Carrier Proteins | 3 | 2022 | 4940 | 0.090 |
Why?
|
| Cluster Analysis | 2 | 2015 | 2727 | 0.090 |
Why?
|
| Brain Waves | 1 | 2016 | 418 | 0.090 |
Why?
|
| Brain Injuries | 2 | 2014 | 2059 | 0.090 |
Why?
|
| Vocabulary | 1 | 2012 | 167 | 0.090 |
Why?
|
| Physical Fitness | 1 | 2016 | 744 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2017 | 1877 | 0.090 |
Why?
|
| Medication Adherence | 2 | 2020 | 2189 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2013 | 5033 | 0.090 |
Why?
|
| Pesticides | 1 | 2014 | 299 | 0.090 |
Why?
|
| Research Design | 5 | 2020 | 6209 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 1382 | 0.090 |
Why?
|
| Methylation | 3 | 2023 | 1076 | 0.090 |
Why?
|
| Pandemics | 5 | 2022 | 8750 | 0.090 |
Why?
|
| Mercury | 1 | 2014 | 289 | 0.090 |
Why?
|
| Aorta | 1 | 2019 | 2046 | 0.090 |
Why?
|
| Karnofsky Performance Status | 3 | 2020 | 167 | 0.090 |
Why?
|
| Topotecan | 1 | 2011 | 131 | 0.090 |
Why?
|
| Meat | 1 | 2014 | 588 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2811 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2022 | 7885 | 0.090 |
Why?
|
| Motor Activity | 1 | 2021 | 2720 | 0.090 |
Why?
|
| Models, Biological | 5 | 2019 | 9494 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2013 | 2177 | 0.090 |
Why?
|
| Point Mutation | 1 | 1996 | 1595 | 0.090 |
Why?
|
| Anxiety | 2 | 2024 | 4675 | 0.090 |
Why?
|
| Hyperplasia | 1 | 2014 | 1152 | 0.090 |
Why?
|
| Pulse Radiolysis | 3 | 2001 | 6 | 0.090 |
Why?
|
| Fishes | 1 | 2014 | 606 | 0.090 |
Why?
|
| Technology | 2 | 2023 | 296 | 0.090 |
Why?
|
| Arm | 2 | 2024 | 590 | 0.090 |
Why?
|
| Nitro Compounds | 2 | 2024 | 74 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 4357 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2019 | 2025 | 0.090 |
Why?
|
| Colon | 1 | 2018 | 1805 | 0.090 |
Why?
|
| Body Weight | 2 | 2019 | 4630 | 0.090 |
Why?
|
| Hemolysis | 1 | 2012 | 418 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2014 | 792 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2019 | 2257 | 0.090 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 830 | 0.090 |
Why?
|
| Naphthols | 1 | 2010 | 46 | 0.090 |
Why?
|
| Mandatory Testing | 1 | 2010 | 23 | 0.090 |
Why?
|
| Health Expenditures | 1 | 2023 | 2395 | 0.090 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2015 | 587 | 0.090 |
Why?
|
| Receptors, Steroid | 2 | 2021 | 156 | 0.090 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 365 | 0.090 |
Why?
|
| Drug Therapy | 3 | 2019 | 504 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 1795 | 0.090 |
Why?
|
| Life Change Events | 1 | 1995 | 962 | 0.090 |
Why?
|
| Copper | 1 | 2013 | 369 | 0.090 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2010 | 69 | 0.090 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2009 | 13 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2066 | 0.090 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2014 | 350 | 0.090 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 1679 | 0.090 |
Why?
|
| Amniotic Fluid | 2 | 2022 | 381 | 0.090 |
Why?
|
| Sample Size | 1 | 2013 | 848 | 0.080 |
Why?
|
| Genome-Wide Association Study | 6 | 2022 | 12775 | 0.080 |
Why?
|
| Anemia | 1 | 2019 | 1520 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1111 | 0.080 |
Why?
|
| Laryngoscopes | 1 | 2011 | 147 | 0.080 |
Why?
|
| Seeds | 2 | 2021 | 124 | 0.080 |
Why?
|
| Molecular Sequence Data | 6 | 2013 | 17626 | 0.080 |
Why?
|
| Axilla | 2 | 2023 | 628 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2022 | 2913 | 0.080 |
Why?
|
| Early Detection of Cancer | 3 | 2021 | 3236 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1356 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 3 | 2024 | 2038 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2021 | 1539 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2019 | 1309 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1758 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2749 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2019 | 6277 | 0.080 |
Why?
|
| Platinum | 2 | 2021 | 222 | 0.080 |
Why?
|
| Blood-Brain Barrier | 2 | 2018 | 1033 | 0.080 |
Why?
|
| Gonorrhea | 1 | 2014 | 355 | 0.080 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 336 | 0.080 |
Why?
|
| Hot Flashes | 1 | 2012 | 330 | 0.080 |
Why?
|
| Thiocyanates | 1 | 2009 | 70 | 0.080 |
Why?
|
| Odds Ratio | 6 | 2021 | 9681 | 0.080 |
Why?
|
| Myeloproliferative Disorders | 2 | 2010 | 614 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2013 | 624 | 0.080 |
Why?
|
| Acute Coronary Syndrome | 1 | 2022 | 2192 | 0.080 |
Why?
|
| Ribosomal Proteins | 1 | 2011 | 370 | 0.080 |
Why?
|
| Esophageal Neoplasms | 2 | 2010 | 1675 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 3440 | 0.080 |
Why?
|
| Oocytes | 1 | 2014 | 1171 | 0.080 |
Why?
|
| Bone Marrow Cells | 4 | 2014 | 2414 | 0.080 |
Why?
|
| Reproduction | 1 | 2013 | 646 | 0.080 |
Why?
|
| Diarrhea | 2 | 2019 | 1320 | 0.080 |
Why?
|
| Temporal Lobe | 1 | 2017 | 1728 | 0.080 |
Why?
|
| Chlorides | 1 | 2012 | 663 | 0.080 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2012 | 359 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2016 | 941 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 2202 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2014 | 3681 | 0.080 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 507 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2820 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 665 | 0.080 |
Why?
|
| Amphotericin B | 1 | 1988 | 143 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 520 | 0.080 |
Why?
|
| Postoperative Nausea and Vomiting | 2 | 2019 | 128 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2018 | 2125 | 0.080 |
Why?
|
| Cardiomyopathies | 2 | 2011 | 2056 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3431 | 0.080 |
Why?
|
| Flavonoids | 2 | 2023 | 447 | 0.080 |
Why?
|
| Commerce | 1 | 2014 | 612 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2011 | 248 | 0.080 |
Why?
|
| Severity of Illness Index | 5 | 2023 | 15939 | 0.080 |
Why?
|
| Gentamicins | 1 | 1989 | 244 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2016 | 1080 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2024 | 14736 | 0.080 |
Why?
|
| Developing Countries | 3 | 2014 | 2903 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 796 | 0.080 |
Why?
|
| Gadolinium | 2 | 2020 | 965 | 0.080 |
Why?
|
| Lymphatic Irradiation | 1 | 2008 | 115 | 0.080 |
Why?
|
| Stroke Volume | 4 | 2022 | 5620 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4411 | 0.070 |
Why?
|
| Culture | 1 | 2012 | 623 | 0.070 |
Why?
|
| Cities | 3 | 2014 | 543 | 0.070 |
Why?
|
| Nausea | 2 | 2021 | 682 | 0.070 |
Why?
|
| Protein Conformation | 5 | 2019 | 3957 | 0.070 |
Why?
|
| Attention | 2 | 2018 | 2425 | 0.070 |
Why?
|
| Gestational Age | 3 | 2021 | 3615 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 797 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2013 | 1149 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 13019 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 1548 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2017 | 1923 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4785 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2015 | 873 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 756 | 0.070 |
Why?
|
| Urban Population | 1 | 1995 | 2045 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2018 | 2894 | 0.070 |
Why?
|
| Polyglutamic Acid | 1 | 2007 | 47 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3230 | 0.070 |
Why?
|
| Infertility | 1 | 2014 | 655 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2542 | 0.070 |
Why?
|
| Mitochondria | 1 | 2020 | 3675 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2019 | 720 | 0.070 |
Why?
|
| Reward | 1 | 2014 | 984 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3252 | 0.070 |
Why?
|
| Nanotechnology | 1 | 2013 | 714 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 1006 | 0.070 |
Why?
|
| Ki-67 Antigen | 2 | 2021 | 628 | 0.070 |
Why?
|
| Developed Countries | 3 | 2014 | 452 | 0.070 |
Why?
|
| Heparin | 1 | 2014 | 1636 | 0.070 |
Why?
|
| Prefrontal Cortex | 1 | 2017 | 2257 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2012 | 1005 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2016 | 2143 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 2491 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 1 | 2010 | 545 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 550 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2013 | 864 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7861 | 0.070 |
Why?
|
| Feasibility Studies | 5 | 2024 | 5311 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 561 | 0.070 |
Why?
|
| Europe | 3 | 2023 | 3439 | 0.070 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2015 | 939 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 599 | 0.070 |
Why?
|
| Escherichia coli | 2 | 2013 | 4209 | 0.070 |
Why?
|
| Troponin I | 1 | 2011 | 662 | 0.070 |
Why?
|
| Perception | 1 | 2013 | 1206 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 2226 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2019 | 3064 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 2537 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 3048 | 0.070 |
Why?
|
| Tongue | 1 | 2009 | 406 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3381 | 0.070 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 743 | 0.070 |
Why?
|
| Photons | 1 | 2010 | 594 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2022 | 4031 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3267 | 0.060 |
Why?
|
| Epirubicin | 1 | 2005 | 81 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 1885 | 0.060 |
Why?
|
| Risk Assessment | 7 | 2024 | 24316 | 0.060 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2009 | 278 | 0.060 |
Why?
|
| Fertilization in Vitro | 1 | 2014 | 1302 | 0.060 |
Why?
|
| Sepsis | 2 | 2018 | 2601 | 0.060 |
Why?
|
| Brain Mapping | 2 | 2018 | 6740 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 691 | 0.060 |
Why?
|
| Epigenesis, Genetic | 4 | 2022 | 3826 | 0.060 |
Why?
|
| Chromones | 2 | 2019 | 148 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3080 | 0.060 |
Why?
|
| Drug Administration Schedule | 3 | 2019 | 4859 | 0.060 |
Why?
|
| Mental Health | 1 | 2020 | 3276 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2013 | 1817 | 0.060 |
Why?
|
| Health Status Disparities | 2 | 2014 | 1882 | 0.060 |
Why?
|
| Seasons | 3 | 2017 | 1526 | 0.060 |
Why?
|
| Portugal | 2 | 2017 | 91 | 0.060 |
Why?
|
| Preventive Medicine | 1 | 2007 | 246 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 4047 | 0.060 |
Why?
|
| Genetic Heterogeneity | 2 | 2021 | 737 | 0.060 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 3412 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2017 | 6606 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 3836 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1094 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2018 | 3199 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2010 | 1026 | 0.060 |
Why?
|
| Neurons | 4 | 2023 | 9512 | 0.060 |
Why?
|
| Software | 2 | 2017 | 4452 | 0.060 |
Why?
|
| Antigen Presentation | 2 | 2021 | 1251 | 0.060 |
Why?
|
| Informed Consent | 1 | 2011 | 1010 | 0.060 |
Why?
|
| Polycythemia Vera | 2 | 2003 | 160 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 6969 | 0.060 |
Why?
|
| Chromosome Duplication | 1 | 2024 | 76 | 0.060 |
Why?
|
| Life Expectancy | 2 | 2022 | 1249 | 0.060 |
Why?
|
| Diet | 3 | 2024 | 8097 | 0.060 |
Why?
|
| Bioreactors | 2 | 2023 | 246 | 0.060 |
Why?
|
| Contraceptive Agents, Male | 2 | 1995 | 8 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 6228 | 0.060 |
Why?
|
| Time | 2 | 2019 | 546 | 0.060 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2014 | 148 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 4076 | 0.060 |
Why?
|
| Fatigue | 2 | 2022 | 1555 | 0.060 |
Why?
|
| Hypertension | 1 | 2024 | 8615 | 0.060 |
Why?
|
| Splenectomy | 1 | 2006 | 392 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2017 | 2029 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1169 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2018 | 3981 | 0.060 |
Why?
|
| Abortion, Induced | 2 | 2020 | 475 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2021 | 4748 | 0.060 |
Why?
|
| Estrogens | 2 | 2021 | 1534 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3411 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 1999 | 4543 | 0.060 |
Why?
|
| Neoplastic Processes | 1 | 2023 | 36 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 3835 | 0.060 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2006 | 214 | 0.060 |
Why?
|
| Americas | 1 | 2023 | 110 | 0.060 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2024 | 101 | 0.060 |
Why?
|
| Lymph Node Excision | 2 | 2023 | 1274 | 0.060 |
Why?
|
| Hypertension, Portal | 1 | 2006 | 230 | 0.060 |
Why?
|
| Anesthetics | 3 | 2014 | 525 | 0.060 |
Why?
|
| Poaceae | 1 | 2023 | 27 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 4584 | 0.050 |
Why?
|
| Transfection | 4 | 2014 | 5758 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2010 | 3411 | 0.050 |
Why?
|
| Pyramidal Cells | 1 | 2006 | 367 | 0.050 |
Why?
|
| Immunocompromised Host | 2 | 2020 | 863 | 0.050 |
Why?
|
| Methane | 1 | 2023 | 44 | 0.050 |
Why?
|
| Dendrites | 1 | 2006 | 472 | 0.050 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 9563 | 0.050 |
Why?
|
| Appendicitis | 1 | 2010 | 689 | 0.050 |
Why?
|
| Binding Sites | 3 | 2017 | 6018 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3431 | 0.050 |
Why?
|
| Postoperative Care | 2 | 2022 | 1479 | 0.050 |
Why?
|
| gamma-Globins | 1 | 2024 | 105 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2021 | 3442 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2044 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5511 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2024 | 1902 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 809 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2024 | 2058 | 0.050 |
Why?
|
| Health Promotion | 2 | 2022 | 2209 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2009 | 2487 | 0.050 |
Why?
|
| Pedigree | 2 | 2021 | 4545 | 0.050 |
Why?
|
| Aconitate Hydratase | 1 | 2022 | 17 | 0.050 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2022 | 33 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 875 | 0.050 |
Why?
|
| Health Surveys | 3 | 2015 | 4056 | 0.050 |
Why?
|
| Drosophila | 1 | 2010 | 1514 | 0.050 |
Why?
|
| Cell Communication | 1 | 2010 | 1660 | 0.050 |
Why?
|
| Motor Vehicles | 2 | 2014 | 282 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2006 | 658 | 0.050 |
Why?
|
| Language | 1 | 2012 | 1558 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 1285 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5802 | 0.050 |
Why?
|
| Calcium | 1 | 2015 | 5794 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 313 | 0.050 |
Why?
|
| Tea | 1 | 2024 | 290 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2020 | 1966 | 0.050 |
Why?
|
| Antibodies | 1 | 2010 | 2425 | 0.050 |
Why?
|
| Smoking | 1 | 2019 | 9109 | 0.050 |
Why?
|
| Anti-Anxiety Agents | 1 | 2024 | 405 | 0.050 |
Why?
|
| Cisplatin | 2 | 2020 | 1661 | 0.050 |
Why?
|
| Epilepsy | 1 | 2017 | 3326 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4209 | 0.050 |
Why?
|
| Isoleucine | 1 | 2001 | 112 | 0.050 |
Why?
|
| Accidents | 1 | 2022 | 164 | 0.050 |
Why?
|
| Base Sequence | 4 | 2021 | 12421 | 0.050 |
Why?
|
| Boronic Acids | 1 | 2006 | 915 | 0.050 |
Why?
|
| Loss of Heterozygosity | 1 | 2024 | 663 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2002 | 4526 | 0.050 |
Why?
|
| Radiology | 1 | 2015 | 2117 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2015 | 3909 | 0.050 |
Why?
|
| Diseases in Twins | 3 | 2000 | 447 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1608 | 0.050 |
Why?
|
| Purine Nucleotides | 1 | 2001 | 27 | 0.050 |
Why?
|
| Africa | 1 | 2023 | 726 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 258 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 165 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 234 | 0.050 |
Why?
|
| Mexico | 1 | 2023 | 767 | 0.050 |
Why?
|
| Spouses | 1 | 2023 | 286 | 0.050 |
Why?
|
| Dental Porcelain | 1 | 2021 | 68 | 0.050 |
Why?
|
| Anorexia | 1 | 2021 | 152 | 0.050 |
Why?
|
| Kentucky | 1 | 2020 | 84 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2024 | 673 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 204 | 0.050 |
Why?
|
| Serine | 1 | 2024 | 831 | 0.050 |
Why?
|
| Cell Survival | 4 | 2015 | 5792 | 0.050 |
Why?
|
| Condylomata Acuminata | 1 | 2001 | 79 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 5192 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2007 | 1434 | 0.040 |
Why?
|
| Age Distribution | 2 | 2018 | 2877 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2024 | 1157 | 0.040 |
Why?
|
| Ascomycota | 1 | 2021 | 81 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2005 | 722 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2006 | 877 | 0.040 |
Why?
|
| Cations | 1 | 2001 | 240 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2024 | 475 | 0.040 |
Why?
|
| Blastocyst | 1 | 2023 | 432 | 0.040 |
Why?
|
| Antigens, Neoplasm | 2 | 2019 | 1999 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 5375 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2019 | 6987 | 0.040 |
Why?
|
| Reference Values | 2 | 2019 | 4941 | 0.040 |
Why?
|
| DNA Polymerase II | 1 | 2020 | 104 | 0.040 |
Why?
|
| Walking | 1 | 2007 | 1201 | 0.040 |
Why?
|
| Scotland | 1 | 2020 | 142 | 0.040 |
Why?
|
| Portal Vein | 1 | 2023 | 431 | 0.040 |
Why?
|
| Lung Injury | 1 | 2005 | 433 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2022 | 685 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 1839 | 0.040 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 7599 | 0.040 |
Why?
|
| Valine | 1 | 2001 | 410 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 808 | 0.040 |
Why?
|
| Pyrazines | 1 | 2006 | 1206 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 4819 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2021 | 7145 | 0.040 |
Why?
|
| Germ Cells | 1 | 2024 | 643 | 0.040 |
Why?
|
| Indolizines | 1 | 2019 | 30 | 0.040 |
Why?
|
| Minority Groups | 1 | 2007 | 1215 | 0.040 |
Why?
|
| Interpersonal Relations | 2 | 2014 | 1440 | 0.040 |
Why?
|
| RNA, Plant | 1 | 2019 | 30 | 0.040 |
Why?
|
| Hepatitis | 1 | 2021 | 227 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2019 | 72 | 0.040 |
Why?
|
| Brassica rapa | 1 | 2019 | 5 | 0.040 |
Why?
|
| Electron Transport | 1 | 2000 | 211 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2016 | 2632 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2020 | 318 | 0.040 |
Why?
|
| Chromosomes, Plant | 1 | 2019 | 22 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 2022 | 627 | 0.040 |
Why?
|
| Sheep | 1 | 2022 | 1451 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 2019 | 81 | 0.040 |
Why?
|
| SOXE Transcription Factors | 1 | 2019 | 73 | 0.040 |
Why?
|
| Pregnancy, High-Risk | 1 | 2020 | 121 | 0.040 |
Why?
|
| Ultrasonics | 1 | 2020 | 208 | 0.040 |
Why?
|
| Recurrence | 2 | 2013 | 8501 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2022 | 846 | 0.040 |
Why?
|
| Leukemia, Myeloid | 1 | 2002 | 693 | 0.040 |
Why?
|
| Side-Population Cells | 1 | 2019 | 12 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2024 | 647 | 0.040 |
Why?
|
| Exons | 2 | 2014 | 2392 | 0.040 |
Why?
|
| Biological Clocks | 1 | 2001 | 321 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2014 | 461 | 0.040 |
Why?
|
| Necrosis | 1 | 2003 | 1619 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 257 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2020 | 267 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 2021 | 444 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2021 | 251 | 0.040 |
Why?
|
| Genetic Speciation | 1 | 2019 | 38 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 3060 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 2009 | 749 | 0.040 |
Why?
|
| Hong Kong | 1 | 2019 | 168 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3859 | 0.040 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2019 | 103 | 0.040 |
Why?
|
| Microcirculation | 1 | 2023 | 1282 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2003 | 1837 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 710 | 0.040 |
Why?
|
| Homozygote | 1 | 2023 | 1779 | 0.040 |
Why?
|
| Argininosuccinate Synthase | 1 | 2018 | 16 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 1149 | 0.040 |
Why?
|
| Intrauterine Devices | 1 | 2000 | 117 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2023 | 942 | 0.040 |
Why?
|
| Educational Status | 2 | 2019 | 2518 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 501 | 0.040 |
Why?
|
| Antispermatogenic Agents | 1 | 1998 | 1 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2023 | 577 | 0.040 |
Why?
|
| Ecuador | 1 | 2018 | 62 | 0.040 |
Why?
|
| Vegetables | 1 | 2024 | 1200 | 0.040 |
Why?
|
| Tropical Climate | 1 | 2018 | 35 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2019 | 293 | 0.040 |
Why?
|
| Cell Cycle | 3 | 2014 | 2934 | 0.040 |
Why?
|
| Pyridoxal Phosphate | 1 | 2018 | 120 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2002 | 900 | 0.040 |
Why?
|
| Observer Variation | 1 | 2024 | 2623 | 0.040 |
Why?
|
| Ribavirin | 1 | 2020 | 395 | 0.040 |
Why?
|
| Radiotherapy Dosage | 2 | 2015 | 2920 | 0.040 |
Why?
|
| Community-Based Participatory Research | 1 | 2020 | 223 | 0.040 |
Why?
|
| Fresh Water | 1 | 2018 | 84 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
| Amino Acids | 2 | 2001 | 1716 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2022 | 703 | 0.040 |
Why?
|
| Policy | 1 | 2022 | 514 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 187 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2021 | 545 | 0.040 |
Why?
|
| Endotoxins | 2 | 2014 | 520 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 584 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2012 | 5408 | 0.040 |
Why?
|
| Epigenomics | 1 | 2023 | 959 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2019 | 255 | 0.040 |
Why?
|
| Philadelphia | 1 | 2018 | 271 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2017 | 19019 | 0.040 |
Why?
|
| Oncogenes | 2 | 2021 | 1234 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2015 | 1955 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 861 | 0.040 |
Why?
|
| Neuroglia | 1 | 2023 | 960 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2008 | 2693 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 2017 | 1895 | 0.040 |
Why?
|
| Water | 1 | 2024 | 1418 | 0.040 |
Why?
|
| Premenopause | 1 | 2021 | 1039 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2022 | 1011 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2019 | 1830 | 0.040 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2017 | 110 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2018 | 247 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 372 | 0.040 |
Why?
|
| Physicians | 1 | 2015 | 4614 | 0.040 |
Why?
|
| Aza Compounds | 1 | 2017 | 34 | 0.040 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 126 | 0.040 |
Why?
|
| Medicare | 4 | 2018 | 6881 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2006 | 1515 | 0.040 |
Why?
|
| Cytogenetic Analysis | 1 | 2018 | 270 | 0.040 |
Why?
|
| Skull Base | 1 | 2020 | 294 | 0.030 |
Why?
|
| Mental Recall | 2 | 2014 | 1226 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1999 | 424 | 0.030 |
Why?
|
| Microsatellite Instability | 1 | 2020 | 726 | 0.030 |
Why?
|
| HLA-A Antigens | 1 | 2017 | 223 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2022 | 1094 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2018 | 6350 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9618 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 1997 | 148 | 0.030 |
Why?
|
| Rotavirus | 1 | 2018 | 110 | 0.030 |
Why?
|
| Nerve Net | 2 | 2021 | 2362 | 0.030 |
Why?
|
| Vomiting | 1 | 2020 | 655 | 0.030 |
Why?
|
| Exanthema | 1 | 2021 | 503 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2018 | 350 | 0.030 |
Why?
|
| Ions | 1 | 2017 | 256 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 928 | 0.030 |
Why?
|
| Protein Binding | 3 | 2014 | 9346 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2009 | 2819 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1996 | 221 | 0.030 |
Why?
|
| Spleen | 2 | 2018 | 2295 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 2017 | 244 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2015 | 8747 | 0.030 |
Why?
|
| Panic Disorder | 1 | 2000 | 613 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2256 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2017 | 419 | 0.030 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2016 | 83 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 466 | 0.030 |
Why?
|
| Neck | 1 | 2021 | 736 | 0.030 |
Why?
|
| Epididymis | 2 | 1995 | 227 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5857 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 857 | 0.030 |
Why?
|
| Missouri | 1 | 2016 | 113 | 0.030 |
Why?
|
| Mexican Americans | 1 | 1997 | 164 | 0.030 |
Why?
|
| Spermatozoa | 2 | 1998 | 631 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2022 | 1493 | 0.030 |
Why?
|
| Urea | 1 | 2018 | 446 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1416 | 0.030 |
Why?
|
| Oxonic Acid | 1 | 2015 | 31 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 544 | 0.030 |
Why?
|
| Tegafur | 1 | 2015 | 39 | 0.030 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 2661 | 0.030 |
Why?
|
| Cell Count | 2 | 2015 | 1833 | 0.030 |
Why?
|
| World Health Organization | 1 | 2022 | 1327 | 0.030 |
Why?
|
| Antitubercular Agents | 2 | 2015 | 1391 | 0.030 |
Why?
|
| Verbal Behavior | 1 | 2017 | 336 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 1364 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2298 | 0.030 |
Why?
|
| CpG Islands | 1 | 2020 | 1208 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1996 | 767 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2015 | 48 | 0.030 |
Why?
|
| Cyclins | 1 | 1997 | 606 | 0.030 |
Why?
|
| Sulfones | 1 | 1998 | 448 | 0.030 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2015 | 58 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2022 | 1092 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2018 | 378 | 0.030 |
Why?
|
| Agaricales | 1 | 2015 | 31 | 0.030 |
Why?
|
| Demography | 1 | 1999 | 1642 | 0.030 |
Why?
|
| Energy-Generating Resources | 1 | 2014 | 5 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2005 | 1925 | 0.030 |
Why?
|
| Dogs | 1 | 2019 | 3846 | 0.030 |
Why?
|
| Manitoba | 1 | 2014 | 24 | 0.030 |
Why?
|
| Calcitriol | 1 | 1996 | 303 | 0.030 |
Why?
|
| Fetal Hemoglobin | 1 | 2017 | 346 | 0.030 |
Why?
|
| Atmosphere | 1 | 2014 | 32 | 0.030 |
Why?
|
| Microspheres | 1 | 2018 | 789 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
| Testis | 2 | 1995 | 783 | 0.030 |
Why?
|
| Human Activities | 1 | 2014 | 26 | 0.030 |
Why?
|
| Sperm Count | 1 | 1995 | 229 | 0.030 |
Why?
|
| Betaine | 1 | 2014 | 90 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2014 | 97 | 0.030 |
Why?
|
| Consanguinity | 1 | 1996 | 460 | 0.030 |
Why?
|
| Air | 1 | 2014 | 187 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 358 | 0.030 |
Why?
|
| Arousal | 1 | 2020 | 1183 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 2106 | 0.030 |
Why?
|
| Chromium | 1 | 2014 | 133 | 0.030 |
Why?
|
| Perfusion | 1 | 2019 | 1402 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2016 | 731 | 0.030 |
Why?
|
| Sperm Motility | 1 | 1995 | 266 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2001 | 1894 | 0.030 |
Why?
|
| Olfactory Perception | 1 | 2014 | 65 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1997 | 664 | 0.030 |
Why?
|
| Genome, Insect | 1 | 2014 | 96 | 0.030 |
Why?
|
| Follicular Fluid | 1 | 2014 | 92 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2018 | 775 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 520 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 552 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1993 | 98 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 2708 | 0.030 |
Why?
|
| Agriculture | 1 | 2015 | 187 | 0.030 |
Why?
|
| Travel | 1 | 2019 | 800 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 1999 | 1395 | 0.030 |
Why?
|
| Retreatment | 1 | 2015 | 600 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2024 | 6430 | 0.030 |
Why?
|
| Gossypol | 1 | 1993 | 23 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 1945 | 0.030 |
Why?
|
| Cattle | 2 | 1989 | 3827 | 0.030 |
Why?
|
| Fertility | 2 | 1995 | 772 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2019 | 964 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 505 | 0.030 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1993 | 175 | 0.030 |
Why?
|
| Lip | 1 | 2014 | 198 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 513 | 0.030 |
Why?
|
| Asia | 1 | 2014 | 627 | 0.030 |
Why?
|
| HIV-1 | 1 | 2010 | 6963 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2593 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2018 | 1530 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 620 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2001 | 2610 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 506 | 0.030 |
Why?
|
| Medical Records | 1 | 2018 | 1413 | 0.030 |
Why?
|
| Hypotension | 1 | 2019 | 889 | 0.030 |
Why?
|
| Methyl Ethers | 1 | 2014 | 196 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 2225 | 0.030 |
Why?
|
| COS Cells | 1 | 2014 | 1135 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2016 | 592 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2020 | 1159 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2014 | 253 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1516 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1362 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2398 | 0.030 |
Why?
|
| Benzoquinones | 1 | 2013 | 198 | 0.030 |
Why?
|
| Association Learning | 1 | 2014 | 223 | 0.030 |
Why?
|
| Industry | 1 | 2014 | 365 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2014 | 8541 | 0.030 |
Why?
|
| Aphasia | 1 | 2014 | 193 | 0.030 |
Why?
|
| Adiposity | 1 | 2022 | 1895 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2002 | 1399 | 0.030 |
Why?
|
| Albumins | 1 | 2015 | 577 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2016 | 755 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2012 | 64 | 0.020 |
Why?
|
| Confidence Intervals | 2 | 2014 | 2931 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2013 | 408 | 0.020 |
Why?
|
| Geography | 1 | 2014 | 654 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2019 | 2205 | 0.020 |
Why?
|
| Unsafe Sex | 1 | 2014 | 239 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2012 | 108 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2019 | 1174 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2016 | 715 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2016 | 797 | 0.020 |
Why?
|
| Crystallization | 1 | 2013 | 523 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1882 | 0.020 |
Why?
|
| Sirolimus | 1 | 2019 | 1542 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2012 | 91 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1516 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 1995 | 549 | 0.020 |
Why?
|
| Introns | 1 | 2014 | 968 | 0.020 |
Why?
|
| Wilms Tumor | 1 | 1994 | 379 | 0.020 |
Why?
|
| Codon | 1 | 2013 | 599 | 0.020 |
Why?
|
| Rats, Wistar | 2 | 2006 | 1890 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2013 | 319 | 0.020 |
Why?
|
| Carbon | 1 | 2015 | 672 | 0.020 |
Why?
|
| Psychometrics | 1 | 2021 | 3069 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 2596 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2018 | 1245 | 0.020 |
Why?
|
| Frontotemporal Dementia | 1 | 2014 | 249 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1397 | 0.020 |
Why?
|
| Temperature | 1 | 2018 | 2234 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 6566 | 0.020 |
Why?
|
| Syphilis | 1 | 2014 | 243 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 862 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 3108 | 0.020 |
Why?
|
| Propensity Score | 1 | 2019 | 1955 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2014 | 704 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 1315 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1972 | 0.020 |
Why?
|
| Substance-Related Disorders | 2 | 1998 | 4429 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 583 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2012 | 404 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 646 | 0.020 |
Why?
|
| Piperidines | 1 | 2019 | 1660 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 1893 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2588 | 0.020 |
Why?
|
| Teniposide | 1 | 2010 | 11 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2012 | 326 | 0.020 |
Why?
|
| Genes | 1 | 1994 | 1824 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3334 | 0.020 |
Why?
|
| Length of Stay | 2 | 2014 | 6516 | 0.020 |
Why?
|
| Remission Induction | 1 | 2016 | 2407 | 0.020 |
Why?
|
| Leptin | 1 | 2018 | 1597 | 0.020 |
Why?
|
| Lipids | 2 | 2014 | 3344 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 848 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2010 | 226 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2010 | 220 | 0.020 |
Why?
|
| Absorption | 1 | 2010 | 243 | 0.020 |
Why?
|
| Carmustine | 1 | 2010 | 137 | 0.020 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 712 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3079 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2017 | 3779 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2020 | 2180 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 3712 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 551 | 0.020 |
Why?
|
| Panax | 1 | 2009 | 28 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1994 | 1064 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 337 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2011 | 370 | 0.020 |
Why?
|
| Cardiac Electrophysiology | 1 | 2009 | 60 | 0.020 |
Why?
|
| Seizures | 1 | 2022 | 3000 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3438 | 0.020 |
Why?
|
| Workload | 1 | 1995 | 852 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2014 | 880 | 0.020 |
Why?
|
| Sulfoxides | 1 | 2009 | 47 | 0.020 |
Why?
|
| Internet | 1 | 2002 | 3107 | 0.020 |
Why?
|
| Plasmids | 1 | 2014 | 2267 | 0.020 |
Why?
|
| Vehicle Emissions | 1 | 2014 | 656 | 0.020 |
Why?
|
| Isothiocyanates | 1 | 2009 | 48 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 610 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3905 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2015 | 2078 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 612 | 0.020 |
Why?
|
| Materials Testing | 1 | 2013 | 872 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2019 | 3579 | 0.020 |
Why?
|
| Mastectomy, Extended Radical | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 1876 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2009 | 199 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 665 | 0.020 |
Why?
|
| Cell Line | 2 | 2018 | 15593 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 6034 | 0.020 |
Why?
|
| Bacteria | 1 | 2019 | 2222 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2000 | 2754 | 0.020 |
Why?
|
| Cause of Death | 1 | 2019 | 3728 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 1762 | 0.020 |
Why?
|
| Hormones | 1 | 2012 | 870 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1988 | 530 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2021 | 6409 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3398 | 0.020 |
Why?
|
| Thiazoles | 1 | 2015 | 1542 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8902 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2014 | 1575 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3612 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 1524 | 0.020 |
Why?
|
| Weight Loss | 1 | 2019 | 2715 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3728 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2661 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2013 | 1595 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1342 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 1988 | 350 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1988 | 218 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 1937 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2448 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5538 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1705 | 0.020 |
Why?
|
| Triglycerides | 1 | 2015 | 2465 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2012 | 1956 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 10266 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 1142 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2010 | 633 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 2050 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 1482 | 0.020 |
Why?
|
| Insulin | 2 | 2014 | 6608 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 4250 | 0.020 |
Why?
|
| Cardia | 1 | 2006 | 61 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1997 | 2588 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 2664 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 2771 | 0.020 |
Why?
|
| Molecular Weight | 2 | 2002 | 2172 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1998 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 1219 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2353 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3443 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2010 | 1090 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14783 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1438 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 843 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2012 | 1397 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 1563 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5451 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 2433 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2011 | 1277 | 0.010 |
Why?
|
| Lung | 2 | 2018 | 10087 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2862 | 0.010 |
Why?
|
| Students | 1 | 2014 | 1744 | 0.010 |
Why?
|
| Critical Illness | 1 | 2017 | 2755 | 0.010 |
Why?
|
| Epithelium | 1 | 1989 | 1609 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2014 | 1516 | 0.010 |
Why?
|
| DNA Damage | 1 | 2014 | 2459 | 0.010 |
Why?
|
| Menopause | 1 | 2012 | 1653 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5711 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2059 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1988 | 1251 | 0.010 |
Why?
|
| Obesity | 2 | 2018 | 13082 | 0.010 |
Why?
|
| Memory | 1 | 2013 | 2210 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1891 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2950 | 0.010 |
Why?
|
| Cell Differentiation | 4 | 2014 | 11659 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 2513 | 0.010 |
Why?
|
| Kinetics | 2 | 2001 | 6334 | 0.010 |
Why?
|
| Eating | 1 | 2010 | 1541 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2006 | 357 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2006 | 715 | 0.010 |
Why?
|
| Dementia | 1 | 2018 | 2728 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3585 | 0.010 |
Why?
|
| Imidazoles | 1 | 2009 | 1168 | 0.010 |
Why?
|
| Rabbits | 1 | 1989 | 4782 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2006 | 519 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 2337 | 0.010 |
Why?
|
| Pneumonia | 1 | 2014 | 2162 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 452 | 0.010 |
Why?
|
| Anesthesia | 1 | 2013 | 1596 | 0.010 |
Why?
|
| RNA, Archaeal | 1 | 2002 | 7 | 0.010 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2002 | 10 | 0.010 |
Why?
|
| Chromatin | 1 | 2014 | 2967 | 0.010 |
Why?
|
| Women's Health | 1 | 2012 | 2078 | 0.010 |
Why?
|
| Emotions | 1 | 2014 | 2768 | 0.010 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2002 | 54 | 0.010 |
Why?
|
| Kidney | 2 | 2014 | 7063 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3692 | 0.010 |
Why?
|
| Peroxidase | 1 | 2005 | 609 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4874 | 0.010 |
Why?
|
| Fermentation | 1 | 2001 | 142 | 0.010 |
Why?
|
| Public Health | 1 | 2014 | 2681 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2006 | 1420 | 0.010 |
Why?
|
| Surface Properties | 1 | 2004 | 1166 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2001 | 315 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9371 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3800 | 0.010 |
Why?
|
| Edema | 1 | 2005 | 766 | 0.010 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2002 | 160 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2001 | 217 | 0.010 |
Why?
|
| Protein Folding | 1 | 2004 | 872 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 2002 | 394 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2001 | 393 | 0.010 |
Why?
|
| Biotechnology | 1 | 2001 | 283 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 2002 | 284 | 0.010 |
Why?
|
| Chromosome Painting | 1 | 1999 | 26 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 1320 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 1999 | 91 | 0.010 |
Why?
|
| Vietnam | 1 | 2000 | 416 | 0.010 |
Why?
|
| Sterilization Reversal | 1 | 1998 | 2 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1999 | 375 | 0.010 |
Why?
|
| Cell Division | 2 | 1997 | 4478 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2001 | 1076 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1999 | 361 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3811 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2002 | 571 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2002 | 1051 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2002 | 2127 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1704 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1988 | 4175 | 0.010 |
Why?
|
| Fabaceae | 1 | 1997 | 104 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 1997 | 150 | 0.010 |
Why?
|
| Phencyclidine | 1 | 1996 | 59 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 1884 | 0.010 |
Why?
|
| Embolization, Therapeutic | 1 | 2006 | 1410 | 0.010 |
Why?
|
| Heroin Dependence | 1 | 1996 | 173 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2002 | 1600 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1997 | 453 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1997 | 449 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2003 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3230 | 0.010 |
Why?
|
| Infertility, Male | 1 | 1998 | 397 | 0.010 |
Why?
|
| Environment | 1 | 2000 | 1125 | 0.010 |
Why?
|
| Social Environment | 1 | 1998 | 1018 | 0.010 |
Why?
|
| Probability | 1 | 1998 | 2482 | 0.010 |
Why?
|
| Stem Cell Factor | 1 | 1993 | 194 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1994 | 268 | 0.010 |
Why?
|
| Granulocytes | 2 | 1988 | 549 | 0.010 |
Why?
|
| Hallucinogens | 1 | 1996 | 207 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3345 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 1994 | 324 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1996 | 410 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 781 | 0.010 |
Why?
|
| Stroke | 1 | 2014 | 9742 | 0.010 |
Why?
|
| Injections | 1 | 1995 | 840 | 0.010 |
Why?
|
| Microscopy | 1 | 1997 | 909 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1993 | 425 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 7242 | 0.010 |
Why?
|
| Genes, ras | 1 | 1994 | 665 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1980 | 2058 | 0.010 |
Why?
|
| Exercise | 1 | 2007 | 5947 | 0.010 |
Why?
|
| Estradiol | 1 | 1997 | 1952 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 13050 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1993 | 892 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1993 | 725 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1993 | 719 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1980 | 3407 | 0.000 |
Why?
|
| Family | 1 | 1998 | 3208 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1994 | 1368 | 0.000 |
Why?
|
| HIV Infections | 1 | 2014 | 17575 | 0.000 |
Why?
|
| Military Personnel | 1 | 1996 | 1265 | 0.000 |
Why?
|
| Culture Media | 1 | 1988 | 898 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1988 | 1769 | 0.000 |
Why?
|
| Veterans | 1 | 1998 | 2672 | 0.000 |
Why?
|
| Sex Factors | 1 | 1998 | 10656 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 15652 | 0.000 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2000 | 4637 | 0.000 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1980 | 209 | 0.000 |
Why?
|
| Erythropoiesis | 1 | 1980 | 693 | 0.000 |
Why?
|